Prelude Therapeutics Inc

Analyst Snapshot

Examining Prelude Therapeutics Inc (PRLD) more closely is necessary

Cameron Mitchell

While Prelude Therapeutics Inc has overperformed by 13.57%, investors are advised to look at stock chart patterns for technical insight. ...

Financial Scores

Prelude Therapeutics Inc’s results are impressive

Kenneth Phillips

While Prelude Therapeutics Inc has overperformed by 8.55%, investors are advised to look at stock chart patterns for technical insight. ...

Financial Scores

Results from Prelude Therapeutics Inc (PRLD) show potential

Cameron Mitchell

While Prelude Therapeutics Inc has overperformed by 5.88%, investors are advised to look at stock chart patterns for technical insight. ...

Market Summary

A closer look at PRLD’s price-to-free cash flow ratio

Cameron Mitchell

Prelude Therapeutics Inc (PRLD)’s stock is trading at $1.84 at the moment marking a fall of -53.81% from the last ...

US Post News
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.